Is Aspire Biopharma Holdings, Inc. technically bullish or bearish?

Sep 20 2025 08:34 PM IST
share
Share Via
As of October 1, 2023, Aspire Biopharma Holdings, Inc. shows a neutral technical trend with a mildly bearish stance, indicated by mixed MACD signals and underperformance of -96.17% year-to-date compared to the S&P 500's 12.22% return.
As of 1 October 2023, the technical trend for Aspire Biopharma Holdings, Inc. is currently neutral with a mildly bearish stance. The weekly MACD indicates a mildly bullish condition, while the monthly MACD is bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly. Bollinger Bands are bullish weekly but bearish monthly. Daily moving averages are mildly bearish, and the KST is mildly bearish weekly with no signal monthly. The On-Balance Volume is bullish for both weekly and monthly periods.

In terms of performance, the stock has significantly underperformed against the S&P 500, with a year-to-date return of -96.17% compared to the S&P 500's 12.22%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%